1. Early Progressing Follicular Lymphoma

   • Danielle Wallace
   • Carla Casulo

   Lymphomas (T Hilal, Section Editor) 19 November 2021 Article: 149

   

2. Treatment Perspectives for Ovarian Cancer in Europe and the United States: Initial Therapy and Platinum-Sensitive Recurrence after PARP Inhibitors or Bevacizumab Therapy

   • Alexandra Lainé
   • Travis T. Sims
   • Robert L. Coleman

   Gynecologic Cancers (J Brown and RW Naumann, Section Editors) 09 November 2021 Article: 148

   

3. Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?

   • Ernesto Rossi
   • Melissa Bersanelli
   • Paolo Andrea Zucali

   Genitourinary Cancers (DP Petrylak and JW Kim, Section Editors) Open access 08 November 2021 Article: 147

   

4. Perioperative NSAIDs and Long-Term Outcomes After cancer Surgery: a Systematic Review and Meta-analysis

   • Shebin Shaji
   • Charlotte Smith
   • Patrice Forget

   Anesthesiology and Critical Care (JP Cata, Section Editor) Open access 08 November 2021 Article: 146

   

5. Cancer-Related Fatigue—Is There a Role for Complementary and Integrative Medicine?

   • Adi David
   • David Hausner
   • Moshe Frenkel

   Integrative Care (C Lammersfeld, Section Editor) 07 November 2021 Article: 145

6. Current Role of Functional Imaging in the Management of Lymphoma

   • Bruce D. Cheson
   • Michel Meignan

   Lymphomas (T Hilal, Section Editor) 04 November 2021 Article: 144

   

7. New Directions in Imaging Neuroendocrine Neoplasms

   • Julie Refardt
   • Johannes Hofland
   • Emanuel Christ

   Neuroendocrine Neoplasms (NS Reed, Section Editor) Open access 04 November 2021 Article: 143

   

8. Is Myelodysplasia a Consequence of Normal Aging?

   • Sonja Heibl
   • Reinhard Stauder
   • Michael Pfeilstöcker

   Geriatric Oncology (L Balducci, Section Editor) Open access 04 November 2021 Article: 142

   

9. Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities

   • Rita Hleihel
   • Abdou Akkouche
   • Hiba El Hajj

   Lymphomas (T Hilal, Section Editor) 04 November 2021 Article: 141

   

10. Circulating Tumour DNA and Colorectal Cancer: the Next Revolutionary Biomarker?

    • Mahendra Naidoo
    • Oliver Piercey
    • Jeanne Tie

    Gastrointestinal Cancers (J Meyer, Section Editor) 04 November 2021 Article: 140

    

11. New Treatments for Recurrent Uterine Cancer

    • Michael D. Toboni
    • Matthew A. Powell

    Gynecologic Cancers (J Brown and RW Naumann, Section Editors) 04 November 2021 Article: 139

    

12. Combined BRAF-Targeted Therapy with Immunotherapy in BRAF-Mutated Advanced Melanoma Patients

    • Pier Francesco Ferrucci
    • Marko Lens
    • Emilia Cocorocchio

    Melanoma (RJ Sullivan, Section Editor) 04 November 2021 Article: 138

13. A New Generation of Vaccines in the Age of Immunotherapy

    • Alfredo Addeo
    • Alex Friedlaender
    • Christian Rolfo

    Lung Cancer (H Borghaei, Section Editor) 04 November 2021 Article: 137

    

14. The Role and Impact of Minimal Residual Disease in NSCLC

    • Daniele Frisone
    • Alex Friedlaender
    • Alfredo Addeo

    Lung Cancer (H Borghaei, Section Editor) Open access 04 November 2021 Article: 136